{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:33:47Z","timestamp":1764239627591},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1733,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1468-1293.2010.00837.x","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T12:00:27Z","timestamp":1274097627000},"page":"54-60","source":"Crossref","is-referenced-by-count":12,"title":["Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy"],"prefix":"10.1111","volume":"12","author":[{"given":"S","family":"Resino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Micheloud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JMa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MaL","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00c1","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB1|cit1","first-page":"862","article-title":"Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children","volume":"42","author":"Resino","year":"2006","journal-title":"6 years of follow-up"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB2|cit2","first-page":"13","article-title":"Prevalence of lipodystrophy in HIV-infected children","volume":"166","author":"Ene","year":"2007","journal-title":"a cross-sectional study"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB3|cit3","first-page":"113","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria","volume":"30","author":"Samaras","year":"2007","journal-title":"associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.inf.0000257427.19764.ff","article-title":"Impact on weight and height with the use of HAART in HIV-infected children","volume":"26","author":"Guillen","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB6|cit6","first-page":"121","article-title":"Body fat changes and lipodystrophy in HIV-infected children","volume":"43","author":"Dzwonek","year":"2006","journal-title":"impact of highly active antiretroviral therapy"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jpeds.2008.04.016","article-title":"Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1","volume":"153","author":"Miller","year":"2008","journal-title":"J Pediatr"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAI.0b013e3181648e16","article-title":"Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children","volume":"47","author":"Tassiopoulos","year":"2008","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB11|cit11","first-page":"45","article-title":"HIV-associated lipodystrophy in children","volume":"3","author":"Krause","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/01.pdr.0000228335.64894.26","article-title":"Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome","volume":"60","author":"Verkauskiene","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/JPEM.2007.20.1.65","article-title":"Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIV-associated facial lipoatrophy","volume":"20","author":"Kim","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365510601045062","article-title":"Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy","volume":"67","author":"Papaevangelou","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB15|cit15","first-page":"27","article-title":"The Spanish HIV BioBank","volume":"6","author":"Garcia-Merino","year":"2009","journal-title":"a model of cooperative HIV research"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB16|cit16","first-page":"1","article-title":"Guidelines for use of antiretroviral agents in pediatric HIV infection","volume":"47","author":"CDC.","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB17|cit17","first-page":"1216","article-title":"Viral load and CD4+T-cells response to HAART in HIV-infected children","volume":"37","author":"Resino","year":"2003","journal-title":"an observational study"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/PL00008400","article-title":"Current evidence for the use of paediatric antiretroviral therapy - a PENTA analysis. Paediatric European Network for the Treatment of AIDS Steering Committee","volume":"159","author":"Sharland","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy","volume":"25","author":"Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/135965350601100601","article-title":"Protease inhibitor effects on triglyceride synthesis and adipokine secretion in human omental and subcutaneous adipose tissue","volume":"11","author":"Cianflone","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB22|cit22","first-page":"860","article-title":"Production of plasminogen activator inhibitor 1 by human adipose tissue","volume":"46","author":"Alessi","year":"1997","journal-title":"possible link between visceral fat accumulation and vascular disease"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB23|cit23","first-page":"61","article-title":"Serum ghrelin levels in obese patients","volume":"52","author":"Rosicka","year":"2003","journal-title":"the relationship to serum leptin levels and soluble leptin receptors levels"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF03345607","article-title":"Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?","volume":"31","author":"Spagnuolo","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB25|cit25","first-page":"141","article-title":"Leptin and Adiponectin in the HIV Associated Metabolic Syndrome","volume":"2","author":"Tsiodras","year":"2006","journal-title":"physiologic and therapeutic implications"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB26|cit26","first-page":"30","article-title":"Changes in body mass index, leptin and adiponectin in Japanese children during a three-year follow-up period","volume":"8","author":"Nishimura","year":"2009","journal-title":"a population-based cohort study"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB27|cit27","first-page":"2","article-title":"Adipokines","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"the missing link between insulin resistance and obesity"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2362.2005.01547.x","article-title":"Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines","volume":"35","author":"He","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00042560-200204150-00003","article-title":"Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy","volume":"29","author":"Koppel","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAI.0b013e3181b93a23","article-title":"Detectable HIV viral load is associated with metabolic syndrome","volume":"52","author":"Squillace","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB31|cit31","first-page":"929","article-title":"HIV increases markers of cardiovascular risk","volume":"23","author":"Calmy","year":"2009","journal-title":"results from a randomized, treatment interruption trial"},{"key":"10.1111\/j.1468-1293.2010.00837.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1089\/088922202320935474","article-title":"Characterizing immune reconstitution after long-term HAART in Pediatric AIDS","volume":"18","author":"Resino","year":"2002","journal-title":"AIDS Res Hum Retrovir"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2010.00837.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1293.2010.00837.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:57:54Z","timestamp":1685599074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2010.00837.x"}},"subtitle":["Kinetics of adipokines in HIV-infected children"],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2010.00837.x","relation":{},"ISSN":["1464-2662"],"issn-type":[{"value":"1464-2662","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}